1. Dyer J. Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem. P T. 2019;44(1):12-14.

2. Ekhaguere OA, Okonkwo IR, Batra M, Hedstrom AB. Respiratory distress syndrome management in resource limited settings-Current evidence and opportunities in 2022. Front Pediatr. 2022;10:961509. [DOI:10.3389/fped.2022.961509] [PMID] []

3. Ettinger M. Antiviral and antibacterial actions of monolaurin and lauric acid. Mol Cell Biochem. 2005;272(1-2):29-34. [DOI:10.1007/s11010-005-6604-1] [PMID]

4. Saichek RE, Reddy KR. Electrokinetically enhanced remediation of hydrophobic organic compounds in soils: a review. Critical reviews in environmental science and technology. 2005;35(2):115-192. [DOI:10.1080/10643380590900237]

5. Vasconcelos T, Marques S, Sarmento B. The biopharmaceutical classification system of excipients. Ther Deliv. 2017;8(2):65-78. [DOI:10.4155/tde-2016-0067] [PMID]

6. Shimogaki H, Takeuchi K, Nishino T, Ohdera M, Kudo T, Ohba K, et al. Purification and properties of a novel surface-active agent-and alkaline-resistant protease from Bacillus sp. Y. Agric Biol Chem.1991;55(9):2251-2258. https://doi.org/10.1080/00021369.1991.10870947 [DOI:10.1271/bbb1961.55.2251] [PMID]

7. Lykkedegn S, Sorensen GL, Beck-Nielsen SS, Christesen HT. The impact of vitamin D on fetal and neonatal lung maturation. a systematic review. Am J Physiol Lung Cell. Mol. 2015;308(7):L587-602. [DOI:10.1152/ajplung.00117.2014] [PMID]

8. Tsao K, Hawgood S, Vu L, Hirose S, Sydorak R, Albanese CT, Farmer DL, Harrison MR, Lee H. Resolution of hydrops fetalis in congenital cystic adenomatoid malformation after prenatal steroid therapy. J Pediatr Surg. 2003;38(3):508-510. [DOI:10.1053/jpsu.2003.50089] [PMID]

9. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics. 1985;76(2):145-153. [DOI:10.1542/peds.76.2.145] [PMID]

10. Szefler SJ. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid. Journal of allergy and clinical immunology. 1999;104(4):S175-83. [DOI:10.1016/S0091-6749(99)70059-X] [PMID]

11. Van Hoogevest P, Wendel A. The use of natural and synthetic phospholipids as pharmaceutical excipients. Eur J Lipid Sci Technol. 2014;116(9):1088-1107. [DOI:10.1002/ejlt.201400219] [PMID] []

12. Sadeghnia A, Tanhaei M, Mohammadizadeh M, Nemati M. A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams. Adv Biomed Res. 2014;3:160. [DOI:10.4103/2277-9175.137875] [PMID] []

13. Hamvas A. Martin RJ, Fanaroff AA, Walsh MC. Fanaroff and Martin's Neonatal- Perinatal Medicine. 9th ed. St. Louis: Elsevier Mosby; 2011. Pathophysiology and management of respiratory distress syndrome; pp. 1106-1111. [DOI:10.1016/B978-0-323-06545-0.00053-4]

14. Pan J, Chen MW, Ni WQ, Fang T, Zhang H, Chen Y, et al. Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19(2):137-141.

15. Berggren E, Liljedahl M, Winbladh B, Andreasson B, Curstedt T, Robertson B, et al. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr. 2000;89:460-464. [DOI:10.1111/j.1651-2227.2000.tb00084.x] [PMID]

16. Yeh TF, Chen CM, Wu SY, Husan Z, Li TC, Hsieh WS, et al. Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2016;193(1):86-95. [DOI:10.1164/rccm.201505-0861OC] [PMID]

17. Jónsson B1, Eriksson M, Söder O, Broberger U, Lagercrantz H. Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease. Acta Paediatr. 2000;89:1449-55. [DOI:10.1111/j.1651-2227.2000.tb02775.x]

18. Moschino L, Nardo D, Bonadies L, Stocchero M, Res G, Priante E, et al. Intra-tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants. Pediatr Pulmonol. 2021;56(7):2114-24. [DOI:10.1002/ppul.25415] [PMID] []

19. Tang W, Chen S, Shi D, Ai T, Zhang L, Huang Y, et al. Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis. Pediatr Pulmonol. 2022;57(2):455-69. [DOI:10.1002/ppul.25759] [PMID]